Global Heart Failure Academy

Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from CSL Vifor.
.png)
16-23 of 23

Overcoming Clinical Inertia in Hyperkalemia Management
CME/CEOvercoming Clinical Inertia in Hyperkalemia Management

Hyperkalemia in CKD and HFrEF…What Am I Missing?
CME/CEHyperkalemia in CKD and HFrEF…What Am I Missing?

A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
CME/CEA Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases

Late-breaking First Response on AFFIRM-AHF
Global Heart Failure AcademyLate-breaking First Response on AFFIRM-AHF

CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
Global Heart Failure AcademyCARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
- advertisement

Balancing RAASi Therapy and Potassium: Understanding How it Works
Global Heart Failure AcademyBalancing RAASi Therapy and Potassium: Understanding How it Works

Mechanisms in Heart Failure: Why Iron Deficiency Matters
Global Heart Failure AcademyMechanisms in Heart Failure: Why Iron Deficiency Matters

































